NCT02749799View on ClinicalTrials.gov

Patient Satisfaction Following Twice Daily Dosing With DFD-01 in Subjects With Moderate Plaque Psoriasis

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Plaque Psoriasis
Interventions
DRUG

DFD-01 (betamethasone dipropionate) Spray, 0.05%

DFD-01 (betamethasone dipropionate) Spray, 0.05% to be applied twice daily on the affected areas (avoiding the face, scalp, groin, axillae and other intertriginous areas) for 28 days.

Trial Locations (4)

40202

Site One, Louisville

47150

Site Two, New Albany

60005

Site Four, Arlington Heights

89129

Site Three, Las Vegas

Sponsors
All Listed Sponsors
collaborator

Prosoft Clinical

OTHER

lead

Primus Pharmaceuticals

INDUSTRY